Active, Not Recruiting
A Study to Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC
NCT07000149
- Conditions
- Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Carcinoma, +15 more
- Locations
-
- Research Site La Jolla, California, United States
- Research Site Aurora, Colorado, United States
- Research Site Boston, Massachusetts, United States
- Research Site New York, United States